首页> 美国卫生研究院文献>British Medical Journal >Cost effectiveness of abdominal aortic aneurysm screening and rescreening in men in a modern context: evaluation of a hypothetical cohort using a decision analytical model
【2h】

Cost effectiveness of abdominal aortic aneurysm screening and rescreening in men in a modern context: evaluation of a hypothetical cohort using a decision analytical model

机译:现代背景下男性腹主动脉瘤筛查和再筛查的成本效益:使用决策分析模型评估假设的队列

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

>Objective To assess the cost effectiveness of different screening strategies for abdominal aortic aneurysm in men, from the perspective of a national health service.>Setting Screening units at regional hospitals.>Participants Hypothetical cohort of 65 year old men from the general population.>Main outcome measures Costs (£ in 2010) and effect on health outcomes (quality adjusted life years (QALYs)).>Results Screening seems to be highly cost effective compared with not screening. The model estimated a 92% probability that some form of screening would be cost effective at a threshold of £20 000 (€24 790; $31 460). If men with an aortic diameter of 25-29 mm at the initial screening were rescreened once after five years, 452 men per 100 000 initially screened would benefit from early detection, whereas lifetime rescreening every five years would detect 794 men per 100 000. We estimated the associated incremental cost effectiveness ratios for rescreening once and lifetime rescreening to be £10 013 and £29 680 per QALY, respectively. The individual probability of being the most cost effective strategy was higher for each rescreening strategy than for the screening once strategy (in view of the £20 000 threshold).>Conclusions This study confirms the cost effectiveness of screening versus no screening and lends further support to considerations of rescreening men at least once for abdominal aortic aneurysm.
机译:>目的:从国家卫生部门的角度评估男性腹主动脉瘤不同筛查策略的成本效益。>设置地区医院的筛查单位。>参与者是一般人群中65岁男性的假想队列。>主要结局指标费用(2010年为£)及其对健康结局的影响(质量调整生命年(QALYs))。 >结果与不进行筛查相比,筛查似乎具有很高的成本效益。该模型估计以某种形式进行筛查的成本效益为92%的可能性为£20 000(€24 790; $ 31 460)。如果在初次筛查时主动脉直径为25-29 mm的男性在五年后重新筛查一次,则最初筛查的每100 000人中有452人将受益于早期发现,而每五年一次的终生筛查将在每100 000中检测794人。估计重新筛选一次和终生重新筛选的相关增量成本效益比分别为每QALY 10英镑013和29英镑680英镑。每种重新筛查策略中最具成本效益的策略的个体概率高于一次筛查策略(鉴于20 000阈值)。>结论本研究证实了筛查与不进行筛查,并进一步支持考虑至少对腹部主动脉瘤进行一次筛查的男性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号